Immuneemerging evidence
LL-37
Antimicrobial peptide for immune defense
LL-37 is the only human cathelicidin-derived antimicrobial peptide. It plays a critical role in innate immunity, defending against bacteria, viruses, and fungi while also modulating inflammatory responses and wound healing.
⚙️ Mechanism of Action
LL-37 disrupts microbial membranes directly and recruits immune cells to infection sites. It also promotes angiogenesis, wound closure, and can modulate adaptive immune responses through dendritic cell activation.
✅ Benefits
- •Broad-spectrum antimicrobial activity
- •Biofilm disruption (Lyme, MRSA)
- •Wound healing acceleration
- •Immune system modulation
- •Anti-inflammatory in chronic conditions
⚠️ Risks & Considerations
- •Limited clinical trial data for therapeutic use
- •Potential cytotoxicity at high concentrations
- •May exacerbate certain autoimmune conditions
- •Sourcing and purity concerns
Latest Videos
1:41New Peptide Could Help Fight Drug-Resistant 'Superbugs'
Voice of America
2,631·8 years ago
0:18The SHOCKING TRUTH About LL-37 Peptide in Psoriasis! #psoriasis
Coffee Break MD
5,645·1 year ago
15:52Why LL-37 Is the Peptide Everyone's Talking About Now
Vitality and Wellness
734·1 month ago
9:48LL-37 Mechanism Of Action
Regan Archibald
2,480·2 weeks ago
8:39LL37: Revolutionizing Antimicrobial Therapy for Infections, Wound Healing, and Immunity
Dr. Adam Sewell, M.D. | Medical Entrepreneur
4,339·11 months ago
Quick Facts
💉
Dosing Range
100–200 mcg/day
⏱️
Half-Life
~4–6 hours
🔄
Typical Cycle
4–8 weeks
⚡
Time to Effect
1–2 weeks
Administration Routes
Subcutaneous injection
Used in Stacks
